文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

采用补充斯佩茨勒-马丁分级系统对中等级别脑动静脉畸形和可手术边界的研究。

Intermediate-grade brain arteriovenous malformations and the boundary of operability using the supplemented Spetzler-Martin grading system.

机构信息

1Department of Neurosurgery, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona and.

2Center for Cerebrovascular Research Department of Anesthesia and Perioperative Care, University of California, San Francisco, California.

出版信息

J Neurosurg. 2021 Jun 25;136(1):125-133. doi: 10.3171/2020.11.JNS203298. Print 2022 Jan 1.


DOI:10.3171/2020.11.JNS203298
PMID:34171830
Abstract

OBJECTIVE: Supplemented Spetzler-Martin grading (Supp-SM), which is the combination of Spetzler-Martin and Lawton-Young grades, was validated as being more accurate than stand-alone Spetzler-Martin grading, but an operability cutoff was not established. In this study, the authors surgically treated intermediate-grade AVMs to provide prognostic factors for neurological outcomes and to define AVMs at the boundary of operability. METHODS: Surgically treated Supp-SM intermediate-grade (5, 6, and 7) AVMs were analyzed from 2011 to 2018 at two medical centers. Worsened neurological outcomes were defined as increased modified Rankin Scale (mRS) scores on postoperative examinations. A second analysis of 2000-2011 data for Supp-SM grade 6 and 7 AVMs was performed to determine the subtypes with improved or unchanged outcomes. Patients were separated into three groups based on nidus size (S1: < 3 cm, S2: 3-6 cm, S3: > 6 cm) and age (A1: < 20 years, A2: 20-40 years, A3: > 40 years), followed by any combination of the combined supplemented grade: low risk (S1A1, S1A2, S2A1), intermediate risk (S2A2, S1A3, S3A1, or high risk (S3A3, S3A2, S2A3). RESULTS: Two hundred forty-six patients had intermediate Supp-SM grade AVMs. Of these patients, 102 had Supp-SM grade 5 (41.5%), 99 had Supp-SM grade 6 (40.2%), and 45 had Supp-SM grade 7 (18.3%). Significant differences in the proportions of patients with worse mRS scores at follow-up were found between the groups, with 24.5% (25/102) of patients in Supp-SM grade 5, 29.3% (29/99) in Supp-SM grade 6, and 57.8% (26/45) in Supp-SM grade 7 (p < 0.001). Patients with Supp-SM grade 7 AVMs had significantly increased odds of worse postoperative mRS scores (p < 0.001; OR 3.7, 95% CI 1.9-7.3). In the expanded cohort of 349 Supp-SM grade 6 AVM patients, a significantly higher proportion of older patients with larger Supp-SM grade 6 AVMs (grade 6+, 38.6%) had neurological deterioration than the others with Supp-SM grade 6 AVMs (22.9%, p = 0.02). Conversely, in an expanded cohort of 197 Supp-SM grade 7 AVM patients, a significantly lower proportion of younger patients with smaller Supp-SM grade 7 AVMs (grade 7-, 19%) had neurological deterioration than the others with Supp-SM grade 7 AVMs (44.9%, p = 0.01). CONCLUSIONS: Patients with Supp-SM grade 7 AVMs are at increased risk of worse postoperative neurological outcomes, making Supp-SM grade 6 an appropriate operability cutoff. However, young patients with small niduses in the low-risk Supp-SM grade 7 group (grade 7-) have favorable postoperative outcomes. Outcomes in Supp-SM grade 7 patients did not improve with surgeon experience, indicating that the operability boundary is a hard limit reflecting the complexity of high-grade AVMs.

摘要

目的:补充斯佩茨勒-马丁分级(Supp-SM)是斯佩茨勒-马丁分级和劳顿-杨分级的结合,被证明比独立的斯佩茨勒-马丁分级更准确,但尚未确定可操作性的界限。在本研究中,作者对中度 AVM 进行了手术治疗,以提供神经功能预后的预测因素,并确定可操作性边界的 AVM。

方法:在两个医疗中心,对 2011 年至 2018 年期间接受手术治疗的补充斯佩茨勒-马丁分级(5、6 和 7)的 AVM 进行了分析。术后检查中改良 Rankin 量表(mRS)评分增加定义为神经功能恶化。对 2000 年至 2011 年期间补充斯佩茨勒-马丁分级 6 和 7 的 AVM 数据进行了第二次分析,以确定改善或未改变结果的亚型。根据病灶大小(S1:<3cm,S2:3-6cm,S3:>6cm)和年龄(A1:<20 岁,A2:20-40 岁,A3:>40 岁)将患者分为三组,然后根据联合补充分级进行任何组合:低风险(S1A1、S1A2、S2A1)、中风险(S2A2、S1A3、S3A1)或高风险(S3A3、S3A2、S2A3)。

结果:246 例患者为中度 Supp-SM 分级 AVM。其中 102 例患者为 Supp-SM 分级 5(41.5%),99 例患者为 Supp-SM 分级 6(40.2%),45 例患者为 Supp-SM 分级 7(18.3%)。在随访时 mRS 评分较差的患者比例在各组之间存在显著差异,Supp-SM 分级 5 患者中有 24.5%(25/102),Supp-SM 分级 6 患者中有 29.3%(29/99),Supp-SM 分级 7 患者中有 57.8%(26/45)(p<0.001)。Supp-SM 分级 7 的 AVM 患者术后 mRS 评分恶化的可能性显著增加(p<0.001;OR 3.7,95%CI 1.9-7.3)。在扩展的 349 例 Supp-SM 分级 6 AVM 患者队列中,与其他 Supp-SM 分级 6 AVM 患者(22.9%,p=0.02)相比,年龄较大且 Supp-SM 分级 6+较大的患者(38.6%)神经功能恶化的比例显著更高。相反,在扩展的 197 例 Supp-SM 分级 7 AVM 患者队列中,与其他 Supp-SM 分级 7 AVM 患者(44.9%,p=0.01)相比,年龄较小且 Supp-SM 分级 7-较小的患者(19%)神经功能恶化的比例显著更低。

结论:Supp-SM 分级 7 的 AVM 患者术后神经功能恶化的风险增加,因此 Supp-SM 分级 6 是一个合适的可操作性界限。然而,低风险 Supp-SM 分级 7 中较小病灶(分级 7-)的年轻患者有良好的术后结果。Supp-SM 分级 7 患者的结果并未随着外科医生经验的增加而改善,这表明可操作性边界是反映高级别 AVM 复杂性的硬性限制。

相似文献

[1]
Intermediate-grade brain arteriovenous malformations and the boundary of operability using the supplemented Spetzler-Martin grading system.

J Neurosurg. 2022-1-1

[2]
Spetzler-Martin Grade III Arteriovenous Malformations: A Comparison of Modified and Supplemented Spetzler-Martin Grading Systems.

Neurosurgery. 2021-5-13

[3]
Microsurgery for Spetzler-Martin Grade I-III Arteriovenous Malformations: Analysis of Surgical Results and Correlation of Lawton-Young Supplementary Grade and Supplemented Spetzler-Martin Score with Functional Outcome.

World Neurosurg. 2020-12

[4]
Stereotactic radiosurgery for intermediate- and high-grade arteriovenous malformations: outcomes stratified by the supplemented Spetzler-Martin grading system.

J Neurosurg. 2023-3-1

[5]
Surgical selection and outcomes among elderly patients with brain arteriovenous malformations.

Neurosurg Focus. 2020-10-1

[6]
Validation of the supplemented Spetzler-Martin grading system for brain arteriovenous malformations in a multicenter cohort of 1009 surgical patients.

Neurosurgery. 2015-1

[7]
A treatment paradigm for high-grade brain arteriovenous malformations: volume-staged radiosurgical downgrading followed by microsurgical resection.

J Neurosurg. 2015-2

[8]
Microsurgery for intracranial arteriovenous malformation: Long-term outcomes in 445 patients.

PLoS One. 2017-3-21

[9]
Microsurgery for cerebral arteriovenous malformations: subgroup outcomes in a consecutive series of 288 cases.

J Neurosurg. 2016-6-10

[10]
The Application of the Novel Grading Scale (Lawton-Young Grading System) to Predict the Outcome of Brain Arteriovenous Malformation.

Neurosurgery. 2019-2-1

引用本文的文献

[1]
Cerebral arteriovenous malformations classification systems in comparison with Spetzler-Martin: A comparative review.

Surg Neurol Int. 2025-5-9

[2]
Advances in sporadic brain arteriovenous malformations: Novel genetic insights, innovative animal models and emerging therapeutic approaches.

J Cereb Blood Flow Metab. 2025-5

[3]
From bench to bedside: murine models of inherited and sporadic brain arteriovenous malformations.

Angiogenesis. 2025-2-3

[4]
Enhancing the quality of evidence, comparability, and reproducibility in brain arteriovenous malformations treated with open surgery research: a systematic review and proposal of a reporting guideline for surgical and clinical outcomes.

Neurosurg Rev. 2024-4-21

[5]
The Role and Therapeutic Implications of Inflammation in the Pathogenesis of Brain Arteriovenous Malformations.

Biomedicines. 2023-10-24

[6]
Surgical management outcomes of intracranial arteriovenous malformations after preoperative embolization: a systematic review and meta-analysis.

Neurosurg Rev. 2022-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索